4Janulis M, Silberman S, Ambegaokar A, et al. Role of mitogen-activated protein kinases and c-JurdAP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts[J]. J Bio Chem, 1999, 274(2):801-813.
5Hsu T, Young MR, Cmarik J, et al. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis[J]. Free Radic Biol Med, 2000,28:1338-1348.
6Zhang Shi-Ai, Wang Ya-Li, Qi Wen-Ming, et al. The expression of c-fos and c-jun incervical cancer[J]. Anatomy magazine, 2001, 24(6): 522-524.
7Cheng Hong-Wei, Suo Ai-Li, Wu Xiang-Long, et al, The expression of c-los in cervical cancer[J]. Shanxi Tumor medical science, 1999, 7(4): 199-202.
8Cheung TH, Leung JO, Chung TK, et al. C-fos overexpression is associated with the pathoneogenesis of invasive cervical cancer [J]. Gynecol Obstet Invest, 1997, 43(3):200-203.
9Dong ZG, Jeffney AM. Hydrolysis of carcinogen-DNA adducts by three classes ofdeoxyribonucleosidase to their corresponding bases[J]. Carcinogenesis,1991,12(6):1125-1128.
10Chen SL, Tsai TZ. Mutation analysis of Human Papillomavirus type 11 E5 oncoprotein[J]. J Virol,1996,70(6):3502-3508.
4Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcionma in young women : a retrospec-tive analysis of 4,975 cases in Japan [ J ]. Eur J Gynaecol Oncol, 2010,31 ( 1 ) :37-43.
5Poljak M, O:trbenk A. The abbott real time high risk HPV test is a clinically validated human papillomavirus assay for triage in the re- ferral population and use in primary cervical cancer screening in women 30 years and older:a review of validation studies [ J ]. Acta Dermatovenerol Alp Panonica Adriat ,2013,22( 2 ) :43-47.
6Nur S, Chuang L, Ramaswamy G. Immunohistochemical character- ization of cancer antigen in uterine cancers [ J ] . Int J Gynecol Cancer,2006,16 ( 5 ) : 1903-1910.
7de Wilde J, De-Castro Arce J, Snijders PJ, et al. Alterations in AP- 1 and AP-1 regulatory genes during HPV-induced carcinogenesis [J]. Cell Onco1,2008,30 ( 1 ) :77-87.
8Maritz MF, van der Watt PJ, Holderness N, et al. Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression[J]. Biol Chem,2011,392(5 ) :439-448.
9Juneja M, Ilm K, Sehlag PM, et al. Promoter identification and tran- scriptional regulation of the metastasis gene MACC1 in coloreetal cancer[J]. Mol Oncol,2013,7 (5) :929-943.
10Lee EJ,Lee S J, Kim S, et al. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP- 9/NF-KB/AP-1 pathway :involvement of the p21WAF1 expression [ J]. Cell Signal ,2013,25 ( 10 ) :2025-2038.
